CRIS Current Research Information System

NANNI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.158
EU - Europa 2.717
AS - Asia 1.751
AF - Africa 165
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.149
GB - Regno Unito 829
VN - Vietnam 613
CN - Cina 590
SE - Svezia 440
DE - Germania 365
SG - Singapore 361
IT - Italia 279
UA - Ucraina 217
IN - India 135
RU - Federazione Russa 129
FR - Francia 122
IE - Irlanda 108
EE - Estonia 75
ZA - Sudafrica 64
CH - Svizzera 55
TG - Togo 42
FI - Finlandia 35
CI - Costa d'Avorio 21
JO - Giordania 20
BG - Bulgaria 19
SC - Seychelles 19
BE - Belgio 16
NG - Nigeria 14
IR - Iran 12
GR - Grecia 10
CA - Canada 9
LB - Libano 5
BR - Brasile 4
CZ - Repubblica Ceca 4
BJ - Benin 3
JP - Giappone 3
PL - Polonia 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CL - Cile 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
NL - Olanda 2
PK - Pakistan 2
RO - Romania 2
BD - Bangladesh 1
BO - Bolivia 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
PT - Portogallo 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 8.802
Salva come PNG Salva come JPEG
Città #
Southend 749
Fairfield 552
Ashburn 347
Chandler 344
Singapore 322
Houston 288
Wilmington 257
Seattle 242
Woodbridge 240
Cambridge 202
Dong Ket 175
Princeton 169
Ann Arbor 166
Jacksonville 149
Santa Clara 137
Boardman 118
Dublin 108
Nanjing 80
Padova 78
Westminster 78
Bern 50
Bologna 49
Jinan 48
Shenyang 47
Berlin 46
Lomé 42
Saint Petersburg 39
Changsha 36
Helsinki 35
Mülheim 34
Hebei 32
Nanchang 32
San Diego 31
Bremen 26
Beijing 23
Milan 23
New York 23
Abidjan 21
Dearborn 21
Amman 20
Guangzhou 20
Turin 20
Mahé 19
Sofia 19
Tianjin 19
Haikou 18
Jiaxing 18
Abeokuta 14
Brussels 14
Medford 14
Des Moines 13
Redwood City 12
Zhengzhou 12
Falls Church 11
Kunming 11
Florence 10
Hangzhou 10
Los Angeles 10
Ningbo 9
Olalla 9
Shanghai 9
Taizhou 9
Falkenstein 8
Norwalk 8
Paris 8
Taiyuan 8
Bühl 7
Lanzhou 7
Mountain View 7
Ottawa 7
Wuhan 7
Kuban 6
Verona 6
Costa Mesa 5
London 5
Monmouth Junction 5
Redmond 5
Fort Worth 4
San Venanzo 4
Shenzhen 4
Springfield 4
Buffalo 3
Ferrara 3
Frankfurt am Main 3
Fremont 3
Fuzhou 3
Qingdao 3
Riva 3
Rome 3
São Paulo 3
Wenzhou 3
Ardabil 2
Budapest 2
Chengdu 2
Edinburgh 2
Genzano Di Roma 2
Hefei 2
Hyderabad 2
Jakarta 2
Jinhua 2
Totale 5.942
Salva come PNG Salva come JPEG
Nome #
A novel model of CCl4-induced cirrosi with ascites in the mouse. 188
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 175
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 174
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 173
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 169
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 169
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 168
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer 161
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 160
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 160
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 148
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 144
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 144
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 143
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 141
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 139
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients 138
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target. 137
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 137
Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease 136
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy 135
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 133
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 129
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 128
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT 127
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 126
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 124
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging. 123
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 123
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 120
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 120
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. 118
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 117
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 116
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 116
The role of (18)F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study. 115
FUNCTIONAL AND HISTOPATHOLOGICAL IMPROVEMENT OF THE POST-INFARCTED RAT HEART UPON MYOBLAST CELL GRAFTING AND RELAXIN THERAPY. 115
The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies. 115
FDG-PET and PET/CT for evaluating soft tissue sarcomas 114
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. 114
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 114
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 112
Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy 110
Small animal PET for the evaluation of an animal model of genital infection 110
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation 107
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection. 105
Imaging with (11)Carbon labelled PET tracers. 104
Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients 103
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 102
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 102
Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4). 101
Present and future of PET and PET/CT in gynaecologic malignancies. 101
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I. 98
Small animal PET in oncology: the road from bench to bedside. 98
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 96
Feasibility of carbidopa premedication in pediatric patients: a pilot study. 96
PET/CT in the management and prognosis of pancreatic exocrine tumors. 95
Positron-emission tomography in gynaecologic malignancies. 95
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 94
PET Tracers Beyond FDG in Prostate Cancer. 90
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 90
Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas. 89
Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs. 88
PET/TC e TC nella stadiazione pre- e post-chemioterapia neoadiuvante in pazienti con carcinoma ovarico ad alto grado di malignità. 87
The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients 85
Dall'imaging anatomico al metabolico (neoplasie del polmone) 83
Preclinical studies with small animal PET 83
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. 83
Follow-up delle neoplasie polmonari 79
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer. 77
Dall'imaging anatomico al metabolico/ Corso monotematico 76
Follow-up / Corso monotematico 76
Linfomi. Imaging metabolico 75
PET-CT: Rare Findings and Diseases 74
Nutraceuticals & gut: phytosterol & ulcerative colits. 67
The clinical use of PET with (11)C-acetate. 64
PET/CT in Oncology 63
Linfomi: imaging metabolico/ Corso monotematico 61
Totale 8.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.381 0 0 0 0 0 0 301 318 333 159 109 161
2020/20211.246 248 90 32 55 17 60 18 83 119 59 78 387
2021/20221.719 429 58 103 144 127 83 29 95 47 86 295 223
2022/20231.539 156 210 93 241 95 116 47 74 240 66 119 82
2023/2024338 38 73 16 31 31 59 20 11 19 18 9 13
2024/2025901 38 280 136 96 265 74 12 0 0 0 0 0
Totale 8.965